Dr . Michael Ruoff
Doctor of law and graduate in business administration. In 2015, co-founded Think.Health Ventures, a boutique seed investor for startups in the German healthcare industry.
After graduation, Patrick's mother predicted that he would either drive a cab or deal narcotics. Mom was right: in 2015 he founded Pedanios with Florian, and in 2019 Cantourage!
Dr. Florian Kainzinger
Member of the Supervisory Board
PhD in health economics and former managing director of Labor Berlin with more than 400 employees at 12 locations in the capital. Co-founder of Think.Health Ventures.
Dr. Florian Holzapfel
Member of the Supervisory Board
Built up Pedanios GmbH, which was later sold to Aurora. Was a board member of a TecDAX company after his time at McKinsey. Founded Cantourage in 2019 with Patrick.
Philip joined the cannabis industry in 2018: He was responsible for the construction of production facilities for Aurora in Europe and later served as CEO of Aurora Europe, responsible for the distribution of medical cannabis in 10 EU countries.
Director of Quality and "Prokuristin"
Constanze is a pharmacist and has been working in the cannabis industry since 2016. As a co-founder, she has been an important part of Cantourage since 2019. She was responsible for obtaining all medicinal and narcotic permits and ensures that they are maintained.
Global Director of Sales und Prokurist
Bernhard started his career in the cannabis industry in 2018 at Aurora, where he founded subsidiaries in several countries. At Cantourage, he was responsible for the launch of the first Canadian Craft Cannabis in Germany.
How we have been shaping the topic of medical cannabis in Germany since the beginning
Patrick Hoffmann and Florian Holzapfel found Pedanios GmbH, the first wholesaler of medical cannabis in Germany. At that time, only about 200 patients in Germany had a special permit to obtain medical cannabis flowers.
Pedanios imports cannabis flowers from Canada for the first time. Grower at the time: The Peace Naturals Project.
On March 10, the "Cannabis as Medicine" law comes into force, allowing doctors in Germany to prescribe cannabis for therapeutic purposes without indication. Within the next 12 months, the number of people treated with medical cannabis in Germany multiplies. From the beginning, Pedanios leads the rapidly growing market.
Pedanios GmbH is sold to the Canadian world market leader Aurora Cannabis Inc. and henceforth operates under the name Aurora Germany, today Aurora Europe.
The current Cantourage management team - back then still in the service of Aurora - wins the tender for cultivation of medical cannabis in Germany.
Florian and Patrick leave Aurora and found Cantourage GmbH together with Norman Ruchholtz, Constanze Pelzer and Mario Reichenbach.
Cantourage enters the German medical cannabis market with its own dronabinol product, breaking the monopoly that existed until then.
Cantourage launches its "Fast Track Access" platform, which allows any licensed cannabis grower worldwide to bring their cannabis flower to Germany.
For the first time, patients in Germany can be supplied with medical cannabis from Jamaica via Cantourage's platform.
Cantourage opens its own cannabis clinic in London in order to be able to supply patients in the United Kingdom with medical cannabis from now on.
With its self-developed dronabinol solution, Cantourage launches the first product innovation on the German dronabinol market in over 20 years.
For the first time, Cantourage's medical cannabis is available in pharmacies for less than half the current black market price.
Cantourage Group SE goes public on the Frankfurt Stock Exchange on November 11, 2022.